Reported by Time ( Tuesday, October 25, 2011), US government recommends HPV Vaccine for boy aged 11 and 12 be vaccinated against human papillomavirus, or HPV, to protect against anal cancer and cancers of the mouth and neck.
As previous blogged (March 2010) research showed HPV vaccine may prevent nasopharyngeal cancer as well.
Update (03/June/2013) Correspondence with Prof Carol Bradford, who lead this research: HPV vaccine will not work for adult or NPC or EB. Prof Bradford:'It only works HPV and only before (a person) exposed to virus.'
2011-09-12
Cancer drug resistance clue found
Cancer drug resistance clue found
8 September 2011
http://www.bbc.co.uk/news/health-14824309
It may be possible to extend the usefulness of cancer drugs by preventing drug resistance in tumours, say researchers.
A study, published in Science Translational Medicine, showed a chemical reaction went into overdrive as resistance developed.
Scientists said drugs were already on the market which interfered with the process.
Cancer Research UK said the field offered "tremendous optimism".
An international team of researchers were investigating the cancer drug cetuximab, which is used to treat colorectal cancer, head and neck cancers and some lung cancers.
It targets a protein - epidermal growth factor receptor (EGFR) - which drives tumour growth.
They said "all patients will ultimately develop resistance to cetuximab" but that little was known about how the resistance developed.
Alternative route
Continue reading the main story
“Start Quote
Research like this gives us tremendous optimism that we're on the cusp of a real revolution in cancer”
End Quote Henry Scowcroft Cancer Research UK
Experiments showed the cancerous cells acted like cars in a traffic jam - when one route was blocked, they found an alternative.
In this case, the tumours replaced the EGFR route with one involving a different protein - ERBB2 - and continued to grow.
Dr Pasi Janne, from the Dana-Farber Cancer Institute in Boston, said: "ERBB2 activates a critical signalling pathway that is not normally blocked by cetuximab, and in this way subverts cetuximab's function.
"Because ERBB2 isn't affected by cetuximab, this is an easy way for cancers to become resistant to the drug."
The researchers said several drugs which target ERBB2 had already been approved so "the findings from the current study can be used to design potential clinical therapies".
However, they caution that there are likely to be other ways that cancers can develop resistance.
Henry Scowcroft, science information manager at Cancer Research UK, said: "Unfortunately, patients' tumours can become resistant to treatment, and understanding why this happens is a major challenge in cancer research.
"This new study is a great example of how researchers are uncovering the molecular tricks cancer cells use to evade treatment, and finding out how to stop them doing so.
"Research like this gives us tremendous optimism that we're on the cusp of a real revolution in cancer, although there's a lot more work to do to make this a reality."
8 September 2011
http://www.bbc.co.uk/news/health-14824309
It may be possible to extend the usefulness of cancer drugs by preventing drug resistance in tumours, say researchers.
A study, published in Science Translational Medicine, showed a chemical reaction went into overdrive as resistance developed.
Scientists said drugs were already on the market which interfered with the process.
Cancer Research UK said the field offered "tremendous optimism".
An international team of researchers were investigating the cancer drug cetuximab, which is used to treat colorectal cancer, head and neck cancers and some lung cancers.
It targets a protein - epidermal growth factor receptor (EGFR) - which drives tumour growth.
They said "all patients will ultimately develop resistance to cetuximab" but that little was known about how the resistance developed.
Alternative route
Continue reading the main story
“Start Quote
Research like this gives us tremendous optimism that we're on the cusp of a real revolution in cancer”
End Quote Henry Scowcroft Cancer Research UK
Experiments showed the cancerous cells acted like cars in a traffic jam - when one route was blocked, they found an alternative.
In this case, the tumours replaced the EGFR route with one involving a different protein - ERBB2 - and continued to grow.
Dr Pasi Janne, from the Dana-Farber Cancer Institute in Boston, said: "ERBB2 activates a critical signalling pathway that is not normally blocked by cetuximab, and in this way subverts cetuximab's function.
"Because ERBB2 isn't affected by cetuximab, this is an easy way for cancers to become resistant to the drug."
The researchers said several drugs which target ERBB2 had already been approved so "the findings from the current study can be used to design potential clinical therapies".
However, they caution that there are likely to be other ways that cancers can develop resistance.
Henry Scowcroft, science information manager at Cancer Research UK, said: "Unfortunately, patients' tumours can become resistant to treatment, and understanding why this happens is a major challenge in cancer research.
"This new study is a great example of how researchers are uncovering the molecular tricks cancer cells use to evade treatment, and finding out how to stop them doing so.
"Research like this gives us tremendous optimism that we're on the cusp of a real revolution in cancer, although there's a lot more work to do to make this a reality."
Colchicine - smart bomb treatment
British flowers are the source of a new cancer drug
By Leila Battison Science reporter (12 September 2011)
http://www.bbc.co.uk/news/science-environment-14855666
The search for more effective cancer treatments may soon harness the healing power of the Autumn crocus.
Researchers are poised to start clinical trials with a new "smart bomb" treatment, derived from the flower, targeted specifically at tumours.
The treatment, called colchicine, was able to slow the growth of and even completely "kill" a range of different cancers, in experiments with mice.
The research was highlighted at the British Science Festival in Bradford.
The team behind it, from the Institute for Cancer Therapeutics (ICT) at the University of Bradford, has published the work in the journal Cancer Research.
The native British Autumn crocus, otherwise known as "meadow saffron" or "naked lady", is recorded in early herbal guides as a treatment for inflammation.
This is because it contains the potent chemical colchicine, which is known to have medicinal properties, including anti-cancer effects.
But colchicine is toxic to other tissues in the body, as well as cancer, so until now its use has been limited.
The researchers at ICT have now altered the colchicine molecule so it is inactive in the body until it reaches the tumour.
Once there, the chemical becomes active and breaks up the blood vessels supplying the tumour, effectively starving it.
This effect is made possible because of enzymes that all tumours produce, whose usual function is to break down the normal cells nearby, allowing the tumour to spread.
The modified colchicine molecule has a protein attached to it that makes it harmless. But the tumour enzyme specifically targets the protein and removes it.
The colchicine is then activated, and the process of breaking down blood vessels and starving the cancerous cells begins.
Optimistic but cautious
One of the things that may make this drug so effective, Professor Patterson said, is that it will be "only active in the tumour, and not cause damage to normal tissue".
Because the enzyme necessary to activate the toxic colchicine is produced only by solid tumours, it may be possible to treat cancers effectively with virtually no side effects to the rest of the body.
Brain tumour SEM The "smart bombs" do not begin to act until they reach tumour tissue
Moreover, as the drug will be activated wherever the enzyme is produced, the delivery mechanism should allow treatment of particularly problematic cases of metastasis, where the cancer spreads from its initial site.
Pre-clinical tests in mice have shown startlingly successful results.
"What we're looking for is a delay in the growth of the tumour," said Professor Patterson.
"But sometimes the treatment is so effective that in half of the studies, the mice appeared to be cured of their cancer. All mice responded to the treatment."
Just one dose of the colchicine produced this remarkable effect. But if it passes clinical tests, the researchers believe it will be used alongside existing cancer treatments, as part of the complex process of tackling the disease.
The researchers hope that the treatment will enter the initial stage of clinical testing at St James's Hospital in Leeds within the next 18 months.
Professor Patterson said that he was "very optimistic about the opportunities of the treatment, but still cautious because everything done to date has been in the laboratory".
Paul Workman, head of cancer therapeutics at the Institute of Cancer Research, called the work an "interesting new approach".
"The project is still at quite an early stage but the results so far look promising in the laboratory models that have been studied," he said.
"If confirmed in more extensive laboratory studies, drugs based on this approach could be very useful as part of combination treatments for various cancers."
By Leila Battison Science reporter (12 September 2011)
http://www.bbc.co.uk/news/science-environment-14855666
The search for more effective cancer treatments may soon harness the healing power of the Autumn crocus.
Researchers are poised to start clinical trials with a new "smart bomb" treatment, derived from the flower, targeted specifically at tumours.
The treatment, called colchicine, was able to slow the growth of and even completely "kill" a range of different cancers, in experiments with mice.
The research was highlighted at the British Science Festival in Bradford.
The team behind it, from the Institute for Cancer Therapeutics (ICT) at the University of Bradford, has published the work in the journal Cancer Research.
The native British Autumn crocus, otherwise known as "meadow saffron" or "naked lady", is recorded in early herbal guides as a treatment for inflammation.
This is because it contains the potent chemical colchicine, which is known to have medicinal properties, including anti-cancer effects.
But colchicine is toxic to other tissues in the body, as well as cancer, so until now its use has been limited.
The researchers at ICT have now altered the colchicine molecule so it is inactive in the body until it reaches the tumour.
Once there, the chemical becomes active and breaks up the blood vessels supplying the tumour, effectively starving it.
This effect is made possible because of enzymes that all tumours produce, whose usual function is to break down the normal cells nearby, allowing the tumour to spread.
The modified colchicine molecule has a protein attached to it that makes it harmless. But the tumour enzyme specifically targets the protein and removes it.
The colchicine is then activated, and the process of breaking down blood vessels and starving the cancerous cells begins.
Optimistic but cautious
One of the things that may make this drug so effective, Professor Patterson said, is that it will be "only active in the tumour, and not cause damage to normal tissue".
Because the enzyme necessary to activate the toxic colchicine is produced only by solid tumours, it may be possible to treat cancers effectively with virtually no side effects to the rest of the body.
Brain tumour SEM The "smart bombs" do not begin to act until they reach tumour tissue
Moreover, as the drug will be activated wherever the enzyme is produced, the delivery mechanism should allow treatment of particularly problematic cases of metastasis, where the cancer spreads from its initial site.
Pre-clinical tests in mice have shown startlingly successful results.
"What we're looking for is a delay in the growth of the tumour," said Professor Patterson.
"But sometimes the treatment is so effective that in half of the studies, the mice appeared to be cured of their cancer. All mice responded to the treatment."
Just one dose of the colchicine produced this remarkable effect. But if it passes clinical tests, the researchers believe it will be used alongside existing cancer treatments, as part of the complex process of tackling the disease.
The researchers hope that the treatment will enter the initial stage of clinical testing at St James's Hospital in Leeds within the next 18 months.
Professor Patterson said that he was "very optimistic about the opportunities of the treatment, but still cautious because everything done to date has been in the laboratory".
Paul Workman, head of cancer therapeutics at the Institute of Cancer Research, called the work an "interesting new approach".
"The project is still at quite an early stage but the results so far look promising in the laboratory models that have been studied," he said.
"If confirmed in more extensive laboratory studies, drugs based on this approach could be very useful as part of combination treatments for various cancers."
New hopes
A collection of researches and break-throughs in cancer treatment:
"Smart bomb" treatment - extracts from the Autumn crocus - called colchicine, was able to slow the growth of and even completely "kill" a range of different cancers, in experiments with mice. (http://www.bbc.co.uk/news/science-environment-14855666 12th September 2011 ). Saved full text
"Cancer drug resistance clue found". It may be possible to extend the usefulness of cancer drugs by preventing drug resistance in tumours, say researchers. (http://www.bbc.co.uk/news/health-14824309 8th September 2011) Saved full text
"Blue Scorpion venom - Vidatox" search results
"Smart bomb" treatment - extracts from the Autumn crocus - called colchicine, was able to slow the growth of and even completely "kill" a range of different cancers, in experiments with mice. (http://www.bbc.co.uk/news/science-environment-14855666 12th September 2011 ). Saved full text
"Cancer drug resistance clue found". It may be possible to extend the usefulness of cancer drugs by preventing drug resistance in tumours, say researchers. (http://www.bbc.co.uk/news/health-14824309 8th September 2011) Saved full text
"Blue Scorpion venom - Vidatox" search results
2011-05-12
11th May 2011
1
In the morning I thanked Danni for being very nice to my client. I wasn't in any good mood. It was not the client, it was me.
Danni told us she passed Reading Boy School yesterday. It is big and classic. She saw boys coming out. Ryan laying on the mat.
I said 'Ryan is going to go to Reading Boy. No doubt' - as if he has already been.
'But I won't be able to see it happened', she gave me a faint smile.
2
Having some argue with Danni about Vidatox. She thought it is too early to consider alternative homoeopathy
But I thought she wasn't even looking at the material I sent her.
Vidatox, a natural organic effective for cancer, based on the diluted venom of the scorpion (Junceus Rhopalurus). http://www.vidatox.it
In the morning I thanked Danni for being very nice to my client. I wasn't in any good mood. It was not the client, it was me.
Danni told us she passed Reading Boy School yesterday. It is big and classic. She saw boys coming out. Ryan laying on the mat.
I said 'Ryan is going to go to Reading Boy. No doubt' - as if he has already been.
'But I won't be able to see it happened', she gave me a faint smile.
2
Having some argue with Danni about Vidatox. She thought it is too early to consider alternative homoeopathy
But I thought she wasn't even looking at the material I sent her.
Vidatox, a natural organic effective for cancer, based on the diluted venom of the scorpion (Junceus Rhopalurus). http://www.vidatox.it
10th May 2011
Haven't been touch this blog for ages - I thought I can leave it behind me forever.
Danni went to see oncologist today. There is no surprise - we have been dodged our heads in the sand last two months.
Since half way during the holiday in Italy, Danni found the pain becoming ever so unbearable. But she managed to be dragged around the museums and galleries.
I found it hard to concentrate on work.
Danni went to see oncologist today. There is no surprise - we have been dodged our heads in the sand last two months.
Since half way during the holiday in Italy, Danni found the pain becoming ever so unbearable. But she managed to be dragged around the museums and galleries.
I found it hard to concentrate on work.
Subscribe to:
Posts (Atom)